(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST
Clinical trial NCT03465722 · COMPLETED
Trial details
- NCT number
- NCT03465722
- Sponsor
- Blueprint Medicines Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-03-09
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.